Jump to main content
Jump to site search

Issue 7, 2018
Previous Article Next Article

Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents

Author affiliations

Abstract

Twenty-four 14-sulfonamide–tetrandrine derivatives as potential anti-cancer agents were synthesized. The synthetic derivatives were investigated for their cytotoxic activity against human cancer cell lines MDA-MB-231, PC3, WM9, HEL and K562. Initially, the IC50 values (50% inhibitory concentrations) of all of the compounds were determined. These derivatives exhibited potent, but distinct, inhibitory effects on the above-mentioned cell lines. Among them, compound 23, which was modified with a 2-naphthalenesulfonyl group at the 14-amino position, showed impressive inhibition of all five cancer cell lines, and especially of MDA-MB-231 cells with an IC50 value of 1.18 ± 0.14 μM. Further mechanism exploration showed that 23 induced potent apoptotic cell death on MDA-MB-231 cancer cells in a concentration-dependent manner. The results revealed that 23 might be a potential anti-cancer drug candidate.

Graphical abstract: Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents

Back to tab navigation

Supplementary files

Publication details

The article was received on 05 Mar 2018, accepted on 24 Apr 2018 and first published on 04 May 2018


Article type: Research Article
DOI: 10.1039/C8MD00125A
Citation: Med. Chem. Commun., 2018,9, 1131-1141
  •   Request permissions

    Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents

    J. Song, J. Lan, C. Chen, S. Hu, J. Song, W. Liu, X. Zeng, H. Lou, Y. Ben-David and W. Pan, Med. Chem. Commun., 2018, 9, 1131
    DOI: 10.1039/C8MD00125A

Search articles by author

Spotlight

Advertisements